Search

Now showing items 1-7 of 7

Inhibition of microRNA function by antimiR oligonucleotides

Type: Journal Paper

Author : Jan Stenvang; Andreas Petri; Morten Lindow; Susanna Obad; Sakari Kauppinen

Year: 2012

Request PDF

The utility of LNA in microRNA-based cancer diagnostics and therapeutics

Type: Journal Paper

Author : Jan Stenvang; Asli N. Silahtaroglu; Morten Lindow; Joacim Elmen; Sakari Kauppinen

Publisher: Elsevier Science

Year: 2008

Request PDF

Therapeutic application of multipotent stem cells

Type: Journal Paper

Author : Hamed Mirzaei; Amirhossein Sahebkar; Laleh Shiri Sichani; Abdullah Moridikia; Sara Nazari; Javid Sadri Nahand; Hossein salehi; Jan Stenvang; Aria Masoudifar; Hamid R. Mirzaei; Mahmoud R. Jaafari

Year: 2017

Request PDF

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer

Type: Journal Paper

Author : Xue Lin; Jan Stenvang; Mads Heilskov Rasmussen; Shida Zhu; Niels Frank Jensen; Line S Tarpgaard; Guangxia Yang; Kirstine Belling; Claus Lindbjerg Andersen; Jian Li; Lars Bolund; Nils Brünner

Year: 2015

Request PDF

Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways

Type: Journal Paper

Author : Stine Ninel Hansen; David Westergaard; Mathilde Borg Houlberg Thomsen; Mette Vistesen; Khoa Nguyen Do; Louise Fogh; Kirstine C. Belling; Jun Wang; Huanming Yang; Ramneek Gupta; Henrik J. Ditzel; José Moreira; Nils Brünner; Jan Stenvang; Anne-Sofie Schrohl

Year: 2015

Request PDF

Drug Resistance in Colorectal Cancer Cell Lines is Partially Associated with Aneuploidy Status in Light of Profiling Gene Expression

Type: Journal Paper

Author : Jiao Guo; Shaohang Xu; Xuanlin Huang; Lin Li; Congmin Zhang; Qingfei Pan; Zhen Ren; Ruo Zhou; Yan Ren; Jin Zi; Lin Wu; Jan Stenvang; Nils Brünner; Bo Wen; Siqi Liu

Year: 2016

Request PDF

High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer

Type: Journal Paper

Author : Mads H. Rasmussen; Niels F. Jensen; Line S. Tarpgaard; Camilla Qvortrup; Maria U. Rømer; Jan Stenvang; Tine P. Hansen; Lise L. Christensen; Jan Lindebjerg; Flemming Hansen; Benny V. Jensen; Torben F. Hansen; Per Pfeiffer; Nils Brünner; Torben F. Ørntoft; Claus L. Andersen

Year: 2013

Request PDF

Search

Inhibition of microRNA function by antimiR oligonucleotides

The utility of LNA in microRNA-based cancer diagnostics and therapeutics

Therapeutic application of multipotent stem cells

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer

Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways

Drug Resistance in Colorectal Cancer Cell Lines is Partially Associated with Aneuploidy Status in Light of Profiling Gene Expression

High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer

Author

Publisher

Year

Type

Language (ISO)

Content Type

Publication Title

Search

Filters

Inhibition of microRNA function by antimiR oligonucleotides

The utility of LNA in microRNA-based cancer diagnostics and therapeutics

Therapeutic application of multipotent stem cells

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer

Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways

Drug Resistance in Colorectal Cancer Cell Lines is Partially Associated with Aneuploidy Status in Light of Profiling Gene Expression

High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer